DSGN - CIK 0001807120
The table below shows Design Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $12.77M | $15.09M | $19.70M | $13.67M | $30.33M | $45.70M |
| Short-term investments | $210.05M | $190.88M | $196.57M | $216.01M | $223.75M | $215.32M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $227.05M |
| $209.03M |
| $219.79M |
| $233.64M |
| $257.24M |
| $264.84M |
| Property, plant & equipment | $824.00K | $1.10M | $1.26M | $1.38M | $1.56M | $1.73M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $230.44M | $211.77M | $222.89M | $237.47M | $261.63M | $269.58M |
| Accounts payable | $2.28M | $1.91M | $1.01M | $3.18M | $1.47M | $1.30M |
| Total current liabilities | $10.19M | $11.17M | $8.75M | $8.24M | $7.43M | $6.39M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $12.39M | $12.05M | $9.85M | $9.56M | $9.18M | $8.34M |
| Retained earnings | -$314.64M | -$281.01M | -$264.01M | -$244.93M | -$213.56M | -$200.52M |
| Total equity | $218.05M | $199.72M | $213.04M | $227.92M | $252.45M | $261.24M |